You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 6,773,703


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,773,703
Title: Protein-containing hydrogels
Abstract:Hydrogel comprising at least one protein and/or enzyme and/or SOD/catalase enzyme mimic and PEGs, and parts of proteins and enzymes and/or recombinant proteins and enzymes, the proteins and/or enzymes being connected to the PEGs via urea groups.
Inventor(s): Ettner; Norbert (Aichach, DE), Schink; Michael (Hamburg, DE), Schreiber; Jorg (Hamburg, DE), Meier; Wolfgang (Basel, CH), Sauer; Marc (Celle, DE)
Assignee: Beiersdorf AG (Hamburg, DE)
Application Number:09/493,887
Patent Claims:1. A protein-containing hydrogel comprising a polyethylene glycol (PEG) matrix to which is bound one or more catalytically active polypeptides or proteins, wherein, (a) the matrix comprises an activated diisocyanato-PEG polymer further comprising unblocked urea groups; (b) the one or more catalytically active polypeptides or proteins possessing free radical scavenging activity; and (c) wherein the one or more catalytically active polypeptides or proteins are directly bound to the diisocyanato-PEG matrix via the unblocked urea groups.

2. The hydrogel of claim 1, wherein the one or more catalytically active polypeptides or proteins is selected from the group consisting of catalase, superoxide dismutase, lactoperoxidase, glutathione peroxidase, myeloperoxidase, thyroid peroxidase, or a mixture thereof.

3. The hydrogel of claim 1, wherein the one or more catalytically active polypeptides or proteins comprise catalase.

4. The hydrogel of claim 1, wherein the one or more catalytically active polypeptides or proteins comprise superoxide dismutase.

5. The hydrogel of claim 2, further comprising one or more metal-porphyrin complexes, and further wherein at least one of the metals is selected from the group consisting of iron, copper, magnesium and manganese.

6. The hydrogel of claim 5, wherein the metal moiety of the metal-porphyrin complexes is selected from the group consisting of iron, copper, magnesium and manganese.

7. The hydrogel of claim 2, wherein the PEG has a molecular weight of from 8,000 to 18,000 g/mol.

8. The hydrogel according to claim 1, wherein the PEGs are activated by aliphatic, aromatic or araliphatic diisocyanates.

9. The hydrogel according to claim 5, wherein the diisocyanate is 1,6 hexamethylene diisocyanate.

10. The hydrogel of claim 1, further comprising one or more catalytically active polypeptides or proteins selected from the group consisting of proteases, metalloproteases and hydrolases.

11. The hydrogel of claim 10, further comprising one or more catalytically active polypeptides or proteins selected from the group consisting of trypsin, collagenase, lysozyme, elastase, and phosphatase.

12. A process for preparing the protein-containing hydrogel of claim 1, the process comprising the steps: (a) preparing the activated diisocyanato-PEG polymer having unblocked urea groups by reacting PEG with a diisocyanate in a solvent, wherein the reacting optionally takes place in the presence of a catalyst; (b) removing the solvent from the activated diisocyanato-PEG polymer; (c) contacting the activated diisocyanato-PEG polymer with the one or more catalytically active polypeptides or proteins under conditions that effectively permit the one or more polypeptides and proteins to covalently attach to the activated diisocyanato-PEG polymer by reacting with the unblocked urea groups.

13. The process of claim 12, wherein the diisocyanate is either an aliphatic, aromatic or araliphatic diisocyanate.

14. The process of claim 12 wherein the diisocyanate is selected from the group consisting of 1,6-hexamethylene diisocyanate, 1,12-dodecane diisocyanate, isophorone diisocyanate, methylcyclohexane 2,4- and/or 2,6-diisocyanate, dicyclohexylmethane 2,4'- and/or 4,4'-diisocyanate, cyclobutane 1,3-diisocyanate, cyclohexane 1,3- and 1,4-diisocyanate, 2,4- and/or 2,6-hexahydrotolylene diisocyanate, hexahydro-1,3- and/or 1,4-phenylene diisocyanate, and 1,3- and 1,4-phenylene diisocyanate, 2,4- and 2,6-tolylene diisocyanate, diphenylmethane 2,4'- and/or 4,4'-diisocyanate and naphthylene 1,5 diisocyanate.

15. The process of claim 12 wherein the diisocyanate is 1,6-hexamethylene diisocyanate.

16. The process of claim 12 wherein the PEG is of a molecular weight between 6,000 g/mol to 35,000 g/mol.

17. The process of claim 12 wherein the PEG is of a molecular weight between 8,000 g/mol to 18,000 g/mol.

18. The process of claim 12 wherein the PEG is of a molecular weight between 10,000 g/mol to 15,000 g/mol.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.